Anecdotal evidence is on par with doterra evidence until there's a well designed clinical trial.

This data is exciting, but not enough to put the seal of approval and flood the world with a drug.

The risk is too high.  Too many devils in details.

And remember... nobody is blocking doctors from using it.  The FDA is just refraining from flooding the world with a premature declaration.